Stock Code: 300363
Stock Abbreviation: Bo Teng Shares
Announcement No.: 2026-052
Chongqing Bo Teng Pharmaceutical Technology Co., Ltd.
Announcement on Accrual of Asset Impairment Provisions and Disposal of Part of Assets for the First Half of 2026
The Company and all members of the Board of Directors guarantee the content of the information disclosure is true, accurate, and complete, and that there are no false records, misleading statements, or major omissions.
To truly reflect the financial status and operating conditions of Chongqing Bo Teng Pharmaceutical Technology Co., Ltd. (hereinafter referred to as the "Company") as of June 30, 2026, based on the principle of prudence and in accordance with the "Accounting Standards for Enterprises" and the Company's relevant accounting policies, the Company held the twelfth meeting of the Sixth Board of Directors on August 20, 2026, and reviewed and approved the "Proposal on Accruing Asset Impairment Provisions and Disposing of Part of Assets." It was agreed that the Company would accrue asset impairment provisions for part of its receivables and inventory in the first half of 2026 financial report. Impairment provisions would be accrued for related fixed assets, construction in progress, intangible assets, long-term deferred expenses, and other non-current assets at the Slovenia R&D and production base. Provisions for inventory price decline would be reversed for part of the inventory, and part of the fixed assets would be disposed of. The relevant situation is hereby announced as follows:
I. Overview of Asset Impairment Provisions and Asset Disposal This Time